Thrombolytic Therapy with Streptokinase and Tissue Plasminogen Activator in a Patient with Suspected Acute Myocardial Infarction: A Decision Analysis

Publisher： Karger

E-ISSN： 1421-9751|91|4|243-249

ISSN： 0008-6312

Source： Cardiology, Vol.91, Iss.4, 1999-10, pp. : 243-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Relationship of Age with Eligibility for Thrombolytic Therapy and Mortality Among Patients with Suspected Acute Myocardial Infarction

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 2, 1994-02 ,pp. : 127-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Usefulness of a Functional Test of Neutralising Streptokinase Antibodies for the Prediction of the Thrombolytic Effect of Streptokinase in Acute Myocardial Infarction

By  

Cardiology, Vol. 100, Iss. 1, 2003-09 ,pp. : 36-40

Karger

Access to resources Recommend Favorite

Effects of Intracoronary Tissue-Type Plasminogen Activator Treatment in Kawasaki Disease and Acute Myocardial Infarction

By  

Cardiology, Vol. 94, Iss. 1, 2000-11 ,pp. : 52-57

Karger

Access to resources Recommend Favorite

Patient refusal of thrombolytic therapy for suspected acute ischemic stroke

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 882-886

John Wiley & Sons Inc

Access to resources Recommend Favorite